Multidistrict Litigation (MDL) in Personal Injury Cases
Multidistrict litigation consolidates large volumes of related federal civil cases before a single district court judge to coordinate pretrial proceedings. This page covers the statutory framework governing MDL, how cases enter and move through the consolidated process, the personal injury scenarios most likely to produce MDL proceedings, and the boundaries that distinguish MDL from comparable procedural tools such as class actions. Understanding this structure matters because MDL proceedings resolve a significant share of the federal civil docket and directly shape how individual claimants experience discovery, bellwether trials, and global settlement negotiations.
Definition and Scope
Multidistrict litigation is a federal procedural mechanism created by 28 U.S.C. § 1407, enacted in 1968. The statute authorizes the transfer of civil actions pending in different federal districts to a single district court for coordinated or consolidated pretrial proceedings when those cases share "one or more common questions of fact." Upon completion of pretrial proceedings, cases are remanded to their original districts for trial unless the parties consent to trial in the transferee court.
The Judicial Panel on Multidistrict Litigation (JPML), a standing federal panel of seven circuit and district judges designated by the Chief Justice of the United States, holds exclusive authority to order MDL transfers (JPML, Rules of Procedure). The JPML evaluates petitions filed by any party in any related action and decides whether transfer will serve "the convenience of parties and witnesses and will promote the just and efficient conduct of the actions" (28 U.S.C. § 1407(a)).
MDL is expressly a pretrial device. It does not convert individual personal injury claims into a single unified lawsuit; each transferred case retains its separate docket number, its own plaintiff, and its own compensatory damages profile. This structural distinction separates MDL from a class action under Federal Rule of Civil Procedure 23, which requires a formal certification order and binds absent class members. In MDL, every claimant is a named party.
By 2022, MDL proceedings accounted for approximately 70 percent of the entire federal civil docket, according to data compiled by the Federal Judicial Center. The concentration of litigation in individual transferee courts — such as the District of New Jersey for pharmaceutical mass torts — gives MDL proceedings outsized practical significance for product liability and medical malpractice claimants.
How It Works
The MDL process moves through five operationally distinct phases.
- Petition and transfer order. Any party in a related federal case petitions the JPML, identifying the common factual questions and proposing a transferee district. The JPML holds a hearing and issues a transfer order if the statutory criteria are met. Alternatively, the JPML may act sua sponte.
- Appointment of lead counsel and case management. The transferee judge typically appoints a Plaintiffs' Steering Committee (PSC) and a Defense Steering Committee from among the attorneys representing parties in the consolidated proceeding. These committees manage discovery on behalf of all claimants, preventing duplicative depositions and document requests across thousands of individual cases.
- Centralized discovery. Master complaints, master discovery requests, and shared document repositories replace case-by-case filings. Depositions of key corporate witnesses occur once, with transcripts available to all plaintiffs. The Federal Rules of Civil Procedure continue to govern the evidentiary standards for this discovery. More detail on discovery mechanics appears in the personal injury discovery process reference.
- Bellwether trials. Rather than trying all cases, the transferee judge selects a representative set of plaintiffs — typically 3 to 10 in initial rounds — whose cases go to trial to generate verdict data. These bellwether verdicts inform settlement negotiations by signaling how juries evaluate liability and damages for particular claimant profiles.
- Remand or global settlement. If no global resolution is reached, the JPML remands individual cases to their originating districts for trial. In practice, the large majority of MDL cases resolve through negotiated global settlement funds rather than individual trials. Structured payment mechanisms — addressed further in structured settlements in personal injury — are common features of MDL resolution agreements.
Common Scenarios
Personal injury MDL proceedings cluster around product categories and industries where a single design, formulation, or corporate practice injures geographically dispersed individuals.
Pharmaceutical and medical device litigation represents the largest segment of active MDL dockets. Cases involving allegedly defective hip implants, hernia mesh products, and prescription drugs with undisclosed side effects routinely generate thousands of filed claims. The Food and Drug Administration (FDA) warning letters, adverse event reporting databases, and premarket approval records become central evidence in these proceedings.
Toxic tort and environmental exposure cases arise when industrial chemicals, herbicides, or environmental contamination affect populations across state lines. Litigation involving herbicide exposure, per- and polyfluoroalkyl substances (PFAS), and asbestos-containing products has historically generated MDL proceedings. The Environmental Protection Agency (EPA) regulatory record frequently enters evidence through expert witnesses retained to establish causation.
Mass casualty product failures — including vehicle defects and consumer product recalls — produce MDL proceedings tied closely to product liability theories and strict liability doctrine.
Aviation and transportation disasters, though less frequent, generate MDL proceedings when a single mechanical failure or operational failure injures passengers across jurisdictions.
In each scenario, the unifying feature is a common factual nexus — typically a shared product, substance, or event — that makes coordinated pretrial proceedings more efficient than parallel litigation in 50 separate districts.
Decision Boundaries
MDL is frequently compared to two related mechanisms: class action litigation and mass tort litigation. The distinctions carry real procedural and substantive consequences for individual plaintiffs.
MDL vs. Class Action
| Feature | MDL | Class Action (Rule 23) |
|---|---|---|
| Individual plaintiff status | Each plaintiff is a named party | Absent class members bound by judgment |
| Certification requirement | None — transfer based on common facts | Formal certification order required |
| Scope | Pretrial coordination only | Can encompass trial and judgment |
| Opt-out right | Not applicable — cases transferred by JPML order | Required for damages classes under Rule 23(b)(3) |
| Settlement binding effect | Individuals must accept separately | Settlement binds certified class |
The class action framework under Federal Rule of Civil Procedure 23 requires the court to certify that common questions predominate and that the class mechanism is superior to individual litigation — a threshold MDL does not require. Courts have frequently declined to certify personal injury mass torts as Rule 23 classes precisely because individual damages questions (pain and suffering, medical expenses, lost wages) predominate over common ones. MDL fills that gap by coordinating pretrial work without forcing certification. For more on class action lawsuits in personal injury, see the dedicated reference page.
MDL vs. Consolidation Under Rule 42
Federal Rule of Civil Procedure 42 permits a single district court to consolidate cases already pending before it. Rule 42 consolidation is a local device; it cannot reach cases in other districts. MDL operates across all federal districts through the JPML's transfer authority.
State court parallel proceedings
28 U.S.C. § 1407 governs only federal cases. State court filings involving the same product or event proceed independently unless parties agree to coordinate informally. This creates parallel state-federal litigation tracks — a structural reality that affects discovery strategy, statute of limitations analysis (addressed in tolling of statutes of limitations), and settlement allocation. Some state courts have created analogous coordinated proceedings under state procedural rules, but those proceedings are not MDL and fall outside the JPML's jurisdiction.
Preservation of individual claims
Transfer under § 1407 does not alter the substantive law applicable to an individual claim. The transferee judge applies the choice-of-law rules of the originating district, meaning that a plaintiff's compensatory damages claim and the applicable statute of limitations remain governed by the law of the state where the case originated. The MDL forum does not homogenize state-law differences; it coordinates fact development while leaving substantive rights intact.